Stay updated on Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:22:28.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.3 and the previous Revision: v3.4.2 label was removed.
    Difference
    0.1%
    Check dated 2026-03-12T00:35:45.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice, which are minor site maintenance updates that do not affect the study details or core content on this page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:52:19.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and updated the revision to v3.4.1 (from v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:43:04.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata labels, including a new 'Last Update Submitted that Met QC Criteria' field and a capitalization change to 'No FEAR Act data'. Replaced the version label with v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:33:34.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. No substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-01-14T03:06:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.